Clinical and cell biological features related to cellular drug resistance of childhood acute lymphoblastic leukemia cells

Keyphrases

• Acute Lymphoblastic Leukemia Cells 100%
• Age Groups 25%
• B-cell Acute Lymphoblastic Leukemia (B-ALL) 50%
• Better Prognosis 25%
• Biological Characteristics 100%
• Cellular Burden 50%
• Cellular Drugs 100%
• Chemotherapy Regimen 25%
• Childhood Acute Lymphoblastic Leukemia 100%
• Daunorubicin 50%
• Doxorubicin 25%
• Drug Resistance 100%
• Drug Resistance Profile 25%
• Drug Susceptibility Testing 25%
• Ifosfamide 25%
• Immunophenotyping 75%
• Initial Diagnosis 25%
• L-asparaginase 50%
• Leukemic Cells 50%
• Mercaptopurine 25%
• Mitoxantrone 25%
• MTT Assay 25%
• Older children 25%
• Pre-B Acute Lymphoblastic Leukemia 75%
• Prednisolone 50%
• ProB 50%
• Prognostic Significance 50%
• Prognostic Value 25%
• T-acute Lymphoblastic Leukemia 50%
• Teniposide 50%
• Thioguanine 25%
• Vindesine 25%
• Working Diagnosis 25%
• Worse Prognosis 25%
• Young children 25%

Biochemistry, Genetics and Molecular Biology

• Asparaginase 33%
• Daunorubicin 33%
• Dexamethasone 16%
• Doxorubicin 16%
• Drug Resistance 100%
• Ifosfamide 16%
• Immunophenotyping 50%
• Mercaptopurine 16%
• Morphology 16%
• MTT Assay 16%
• Prednisolone 33%
• Teniposide 33%
• Tioguanine 16%

Immunology and Microbiology

• Dexamethasone 16%
• Drug Resistance 100%
• Leukemia Cell 100%
• Morphology 16%
• Prednisolone 33%